Orser Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Orser Capital Management, LLC

  • $135 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 02, 2021
SELL
$478.3 - $607.98 $1.43 Million - $1.82 Million
-2,990 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$544.75 - $658.21 $315,955 - $381,761
-580 Reduced 16.25%
2,990 $1.67 Million
Q2 2020

Jul 29, 2020
BUY
$493.32 - $643.92 $1.71 Million - $2.23 Million
3,470 Added 3470.0%
3,570 $2.23 Million
Q3 2019

Oct 31, 2019
BUY
$273.46 - $318.39 $27,345 - $31,839
100 New
100 $27,000

Others Institutions Holding REGN

# of Institutions
1,490
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.44M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Orser Capital Management, LLC Portfolio

Follow Orser Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orser Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orser Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email